127 related articles for article (PubMed ID: 1724793)
1. Phthalocyanine photodynamic therapy of experimental iris neovascularization.
Miller JW; Stinson WG; Gregory WA; el-Koumy HA; Puliafito CA
Ophthalmology; 1991 Nov; 98(11):1711-9. PubMed ID: 1724793
[TBL] [Abstract][Full Text] [Related]
2. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization.
Kliman GH; Puliafito CA; Stern D; Borirakchanyavat S; Gregory WA
Lasers Surg Med; 1994; 15(1):2-10. PubMed ID: 7527887
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675 nm).
Pallikaris IG; Tslimbaris MK; Iliaki OE; Naoumidi II; Georgiades A; Panagopoulos IA
Lasers Surg Med; 1993; 13(2):197-203. PubMed ID: 8464305
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine.
Panagopoulos JA; Svitra PP; Puliafito CA; Gragoudas ES
Arch Ophthalmol; 1989 Jun; 107(6):886-90. PubMed ID: 2730407
[TBL] [Abstract][Full Text] [Related]
5. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser.
Iliaki OE; Naoumidi II; Tsilimbaris MK; Pallikaris IG
Lasers Surg Med; 1996; 19(3):311-23. PubMed ID: 8923426
[TBL] [Abstract][Full Text] [Related]
6. Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate.
Tsilimbaris MK; Pallikaris IG; Naoumidi II; Vlahonikolis IG; Tsakalof AK; Lydataki SE
Lasers Surg Med; 1994; 15(1):19-31. PubMed ID: 7997045
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.
Husain D; Miller JW; Kenney AG; Michaud N; Flotte TJ; Gragoudas ES
Ophthalmology; 1997 Aug; 104(8):1242-50. PubMed ID: 9261310
[TBL] [Abstract][Full Text] [Related]
8. Effect of squalamine on iris neovascularization in monkeys.
Genaidy M; Kazi AA; Peyman GA; Passos-Machado E; Farahat HG; Williams JI; Holroyd KJ; Blake DA
Retina; 2002 Dec; 22(6):772-8. PubMed ID: 12476105
[TBL] [Abstract][Full Text] [Related]
9. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy.
Kliman GH; Puliafito CA; Grossman GA; Gregory WA
Lasers Surg Med; 1994; 15(1):11-8. PubMed ID: 7997044
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms of iris neovascularization secondary to retinal vein occlusion.
Nork TM; Tso MO; Duvall J; Hayreh SS
Arch Ophthalmol; 1989 Apr; 107(4):581-6. PubMed ID: 2468330
[TBL] [Abstract][Full Text] [Related]
12. An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization.
Bhisitkul RB; Robinson GS; Moulton RS; Claffey KP; Gragoudas ES; Miller JW
Arch Ophthalmol; 2005 Feb; 123(2):214-9. PubMed ID: 15710818
[TBL] [Abstract][Full Text] [Related]
13. Regression of experimental iris neovascularization with systemic alpha-interferon.
Miller JW; Stinson WG; Folkman J
Ophthalmology; 1993 Jan; 100(1):9-14. PubMed ID: 7679482
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic laser cyclodestruction with chloroaluminum sulfonated phthalocyanine (CASPc) or Photofrin (PII) vs. Nd:YAG laser cyclodestruction in a pigmented rabbit model.
Hill RA; Esterowitz T; Ryan J; Liaw LH; Nelson JS; Yashiro H; Krasieva T; Berns MW
Lasers Surg Med; 1995; 17(2):166-71. PubMed ID: 8569412
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine.
Ozler SA; Nelson JS; Liggett PE; de Queiroz JM; Berns MW
Arch Ophthalmol; 1992 Apr; 110(4):555-61. PubMed ID: 1562267
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia.
Ortu P; LaMuraglia GM; Roberts WG; Flotte TJ; Hasan T
Circulation; 1992 Mar; 85(3):1189-96. PubMed ID: 1537115
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Tolentino MJ; Miller JW; Gragoudas ES; Chatzistefanou K; Ferrara N; Adamis AP
Arch Ophthalmol; 1996 Aug; 114(8):964-70. PubMed ID: 8694732
[TBL] [Abstract][Full Text] [Related]
18. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.
Husain D; Miller JW; Michaud N; Connolly E; Flotte TJ; Gragoudas ES
Arch Ophthalmol; 1996 Aug; 114(8):978-85. PubMed ID: 8694734
[TBL] [Abstract][Full Text] [Related]
19. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
Adamis AP; Shima DT; Tolentino MJ; Gragoudas ES; Ferrara N; Folkman J; D'Amore PA; Miller JW
Arch Ophthalmol; 1996 Jan; 114(1):66-71. PubMed ID: 8540853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
